Pittman Scott M. - 23 Jan 2026 Form 4/A - Amendment Insider Report for Nuo Therapeutics, Inc. (AURX)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: AURX
Reported as of: 23 Jan 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 02 Jun 2026, 21:49:53 UTC
Original report date: 26 Jan 2026
Prior SEC filing: 01 Aug 2025
Next SEC filing: 02 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ David Jorden, attorney-in-fact

Key filing fact

Pittman Scott M. filed Form 4/A - Amendment for Nuo Therapeutics, Inc. (AURX) on 02 Jun 2026.

Key facts

This page summarizes Pittman Scott M.'s Form 4/A - Amendment filing for Nuo Therapeutics, Inc. (AURX).
3 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 02 Jun 2026, 21:49.

Change

Previous filing in this sequence was filed on 01 Aug 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001674752 Primary reporting owner

Pittman Scott M.

Relationship: Director, 10%+ Owner
Address: C/O NUO THERAPEUTICS, INC., 8285 EL RIO, SUITE190, HOUSTON
Signature: /s/ David Jorden, attorney-in-fact
Signature date: 02 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AURX transaction Derivative

Initial Warrant (right to buy)

Award

Transaction value
Shares: +30,050
Change %
Price: $1.50^*
Shares after: 30,050
Date: 23 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,050
Exercise price: $1.50
Footnotes: F1

AURX transaction Derivative

Second Warrant (right to buy)

Award

Transaction value
Shares: +36,750
Change %
Price: $1.50^*
Shares after: 0
Date: 23 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 36,750
Exercise price: $1.50
Footnotes: F2, F3

AURX transaction Derivative

Prepayment Warrant (right to buy)

Award

Transaction value
Shares: +7,516
Change %
Price: $1.50^*
Shares after: 0
Date: 23 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,516
Exercise price: $1.50
Footnotes: F4, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

This Form 4 amendment corrects the name of warrant issued in the form of an integrated Initial Warrant, which represents Commitment Initial, Origination Initial, and Capital Initial Warrants immediately exercisable for an aggregate of 30,050 shares of Common Stock.

Footnote F2

This Form 4 amendment corrects the name of warrant issued in the form of an integrated Second Warrant, which represents Origination Second Capital Second Warrants.

Footnote F3

Will vest (if at all) on September 30, 2026 provided a Second Funding occurs in accordance with the Loan and Security Agreement dated January 21, 2026 among the Issuer, the Reporting Person, and other parties thereto (the "Loan Agreement").

Footnote F4

Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement.

Footnote F5

Will vest (if at all) upon the occurrence of a Prepayment, but no later than December 31, 2028, in accordance with the Loan Agreement.